Article

Nanoemulsion Based Hydrogel Containing Omega 3 Fatty Acids as a Surrogate of Betamethasone Dipropionate for Topical Delivery

Advanced Science Letters 03/2012; 6:221-231. DOI: 10.1166/asl.2012.2097

ABSTRACT

The aim of the present study was to investigate the potential of nanoemulsion formulation for topical delivery of betamethasone dipropionate (BD) using fish oil (containing omega-3 fatty acids) as the oil phase. BD has anti-inflammatory, immunomodulatory and antiproliferative activity. However, its clinical use is restricted to some extent due to its poor permeability across the skin. So to increase its permeation across the skin, nanoemulsion based gel formulations were prepared and characterised. Fish oil was used as the oil phase and was also exploited for its anti-inflammatory effect along with BD in the treatment of inflammation associated with psoriasis. Nanoemulsion formulations were prepared by aqueous phase titration method, using fish oil, Unitop 100, PEG 400 and water as the oil phase, surfactant, co-surfactant and aqueous phase respectively. Furthermore, different formulations were subjected to physical stability and consequently evaluated for ex vivo permeation and in vivo anti-inflammatory study. The optimized nanoemulsion was converted into hydrogel-thickened nanoemulsion system (HTN) using carbopol 971 and had a viscosity of 98.67 ± 0.06 PaS. The optimized formulation had small average diameter (125 nm) with zeta potential of -39 mv which indicated good long-term stability. In vivo anti-inflammatory activity indicated 87.64% and 48.76% inhibition of inflammation for drug loaded and placebo formulation respectively. Assessment of skin permeation was done by ATR-FTIR, DSC and histopathology studies which indicated changes in the structure of epidermal membrane of skin.

3 Followers
 · 
122 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: The aim of the present study was to investigate the potential of nanoemulsion formulation for topical delivery of Betamethasone Dipropionate (BD) using Salmon fish oil (containing omega-3 fatty acids) as the oil phase. BD has antiinflammatory, immunomodulatory and antiproliferative activity. However, its clinical use is restricted to some extent due to its poor permeability across the skin. Salmon fish oil was used as the oil phase and was also exploited for its anti-inflammatory effect along with BD in the treatment of inflammation associated with psoriasis. Nanoemulsion formulations were prepared by aqueous phase titration method, using Salmon fish oil, tween 80, Transcutol P and water as the oil phase, surfactant, co-surfactant and aqueous phase respectively. Furthermore, different formulations were subjected to evaluate for ex vivo permeation and in vivo anti-inflammatory and irritation study. The optimized nanoemulsion was converted into hydrogel-thickened nanoemulsion system (HTN) using carbopol 971 and had a viscosity of 98.07 ± 0.07 mP. The optimized formulation had small average diameter (129.89 nm) with zeta potential of -36.09 mV which indicated good long-term stability. In vivo anti-inflammatory activity indicated 85.22% and 33.31% inhibition of inflammation for drug loaded and placebo formulation respectively. Anti-inflammatory activity of placebo nanoemulsion reveals that Salmon fish oil having Anti-inflammatory activity and in combination with BD may be useful for psoriasis treatment in future.
    No preview · Article · · International Journal of Drug Development & Research
  • [Show abstract] [Hide abstract]
    ABSTRACT: Curcumin in spite of being an effective chemotherapeutic agent against different type of cancer, suffer from the problem of low systemic bioavailability due to low aqueous solubility, extensive intestinal metabolism and first-pass metabolism when administered via the oral route. The aim of present investigation was to evaluate the potential of nano globules based nanoemulsion formulation for the solubility enhancement of curcumin. The nano globules based formulation was developed using Labrafac Lipophile WL 1349, Unitop FFT 40, PEG 400 and distilled water as an oil, surfactant, co-surfactant and aqueous phase respectively using aqueous titration method. Furthermore, different formulations were subjected to physical stability and consequently evaluated for ex vivo permeation using small intestine. The optimized formulation had small average globule diameter of 58 nm with zeta potential of -32 mv which indicated long-term dispersion stability. The globules were spherical in shape as observed by Transmission electron microscopy. During ex vivo study, the release of curcumin from nanoemulsion was 96.21% and 98.1% in 6 h and 12 h respectively whereas CU suspension was release up to 28.2% at the end of 12 h. This indicated the enhancement of solubility of curcumin in aqueous solution which is the rate limiting step in the absorption of curcumin in the intestine.
    No preview · Article · Nov 2012 · Journal of Nanoscience and Nanotechnology
  • [Show abstract] [Hide abstract]
    ABSTRACT: Psoriasis is a multifactorial autoimmune skin disorder based on irregularities in the T- cell function. The abnormal keratinocyte hyper proliferation in psoriasis arises due to the activation of T-cells which produces rich amount of arachidonic acid leads to generation of various proinflammatory mediators like PGs, LTs, cytokines and adhesion molecules via MAPK/AP-1, EARK1/2 and protein kinase - C (PKCs) activation pathways. Incorporation of naturally occuring bioactives like, omega (ώ) - 3 fatty acids (i.e., EPA and DHA) in a dose dependent manner results in inhibition of various pro-inflammatory mediators and metabolization of EPA and DHA leads to dampening of inflammation and higher resolution of the skin abnromalities. These all due to the promotion of the synthesis of ώ-3 PUFA-derived lipid mediators viz namely resolvins and protectins. These have been widely used alone or in combination with other drugs in the treatment of psoriasis. Despite of their meritorious visages, the use of these bioactives is associated with several hiccups like higher unstability and vulnerable to degradation due to lipid peroxidation, poor and incosistent bioavilability by oral and topical administartion. The potential use of nanomedicines in the delivery of such bioactives have gained wider attention owing to their promising bioavailability enhancement characteristics, improved stability and better efficacy. The present review give an extensive account on ώ-3 fatty acids (EPA and DHA) starting from seedling to apex, including biosynthesis, metabolites, and its mechanism of action in psoriasis. Moreover, barriers in the effective delivery of ώ-3 fatty acids and how nanomedicines can be fit in the scope of its therapeutic delivery in psoriasis are also addressed. Despites numerous advantages, application of EPA-DHA as ώ-3 fatty acids therapeutics in the management of psoriasis are still at an infancy stage. Nanomedicines approach to achieve high bioavailable delivery with safety and stability of ώ-3 fatty acids showing the promising area for the future in psoriasis management.
    No preview · Article · Mar 2013 · Current drug targets
Show more

We use cookies to give you the best possible experience on ResearchGate. Read our cookies policy to learn more.